MA52087A - Nouveaux vecteurs de virus adéno-associés (aav), vecteurs aav ayant une déamidation de capside réduite et leurs utilisations - Google Patents
Nouveaux vecteurs de virus adéno-associés (aav), vecteurs aav ayant une déamidation de capside réduite et leurs utilisationsInfo
- Publication number
- MA52087A MA52087A MA052087A MA52087A MA52087A MA 52087 A MA52087 A MA 52087A MA 052087 A MA052087 A MA 052087A MA 52087 A MA52087 A MA 52087A MA 52087 A MA52087 A MA 52087A
- Authority
- MA
- Morocco
- Prior art keywords
- aav
- vectors
- capside
- deamidation
- adeno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862635964P | 2018-02-27 | 2018-02-27 | |
| US201862635968P | 2018-02-27 | 2018-02-27 | |
| US201862663788P | 2018-04-27 | 2018-04-27 | |
| US201862663797P | 2018-04-27 | 2018-04-27 | |
| US201862667587P | 2018-05-06 | 2018-05-06 | |
| US201862667888P | 2018-05-07 | 2018-05-07 | |
| US201862667881P | 2018-05-07 | 2018-05-07 | |
| US201862677471P | 2018-05-29 | 2018-05-29 | |
| US201862667585P | 2018-05-29 | 2018-05-29 | |
| US201862677474P | 2018-05-29 | 2018-05-29 | |
| US201862703673P | 2018-07-26 | 2018-07-26 | |
| US201862703670P | 2018-07-26 | 2018-07-26 | |
| US201862722382P | 2018-08-24 | 2018-08-24 | |
| US201862722388P | 2018-08-24 | 2018-08-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52087A true MA52087A (fr) | 2021-06-02 |
Family
ID=67809202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052087A MA52087A (fr) | 2018-02-27 | 2019-02-27 | Nouveaux vecteurs de virus adéno-associés (aav), vecteurs aav ayant une déamidation de capside réduite et leurs utilisations |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210123073A1 (fr) |
| EP (1) | EP3768695A4 (fr) |
| JP (1) | JP7498665B2 (fr) |
| KR (1) | KR20210006327A (fr) |
| CN (1) | CN112236443A (fr) |
| AU (1) | AU2019228504A1 (fr) |
| BR (1) | BR112020017278A2 (fr) |
| CA (1) | CA3091795A1 (fr) |
| CL (1) | CL2020002201A1 (fr) |
| IL (1) | IL276860A (fr) |
| MA (1) | MA52087A (fr) |
| MX (1) | MX2020008932A (fr) |
| SG (1) | SG11202007942YA (fr) |
| WO (1) | WO2019169004A1 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202107733QA (en) | 2015-09-28 | 2021-09-29 | Univ North Carolina Chapel Hill | Methods and compositions for antibody-evading virus vectors |
| WO2019195449A1 (fr) | 2018-04-03 | 2019-10-10 | Stridebio, Inc. | Vecteurs de virus évitant les anticorps |
| EP3884057A4 (fr) * | 2018-12-21 | 2022-09-07 | The University of North Carolina at Chapel Hill | Gènes galc optimisés et cassettes d'expression et leur utilisation |
| MX2021011468A (es) | 2019-03-21 | 2021-12-15 | Vectores de virus adenoasociados recombinantes. | |
| WO2021076925A1 (fr) | 2019-10-17 | 2021-04-22 | Stridebio, Inc. | Vecteurs de virus adéno-associés pour le traitement de la maladie de niemann-pick de type c |
| TW202130653A (zh) * | 2019-10-21 | 2021-08-16 | 賓州大學委員會 | 具改進生產產率及肝臟趨性之ａａｖ３ｂ變異體 |
| MX2022008003A (es) * | 2020-01-03 | 2022-10-07 | Sarepta Therapeutics Inc | Métodos para analizar proteínas de la cápside de aav. |
| WO2021183433A1 (fr) * | 2020-03-09 | 2021-09-16 | University Of Massachusetts | Thérapie de remplacement de gène pour le syndrome de foxg1 |
| WO2021257668A1 (fr) | 2020-06-17 | 2021-12-23 | The Trustees Of The University Of Pennsylvania | Compositions et méthodes pour le traitement de patients de thérapie génique |
| IL299762A (en) | 2020-07-13 | 2023-03-01 | Univ Pennsylvania | Useful preparations for the treatment of Charcot-Marietot disease |
| CA3195553A1 (fr) * | 2020-10-18 | 2022-04-21 | Qiang Wang | Vecteur de virus adeno-associe(aav) ameliore et ses utilisations |
| CA3209779A1 (fr) | 2021-02-01 | 2022-08-04 | Regenxbio Inc. | Therapie genique de ceroides-lipofuscinoses neuronales |
| JP2024515612A (ja) | 2021-04-12 | 2024-04-10 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 球脊髄性筋萎縮症（ｓｂｍａ）の治療に有用な組成物 |
| WO2023081807A1 (fr) * | 2021-11-04 | 2023-05-11 | The Trustees of the University of Pennsylvania Penn Center for Innovation | Compositions et procédés pour réduire les taux de pcsk9 chez un sujet |
| WO2023133584A1 (fr) | 2022-01-10 | 2023-07-13 | The Trustees Of The University Of Pennsylvania | Compositions utiles dans le traitement d'une leucodystrophie métachromatique |
| WO2023133574A1 (fr) | 2022-01-10 | 2023-07-13 | The Trustees Of The University Of Pennsylvania | Compositions et méthodes utiles pour le traitement de troubles médiés par c9orf72 |
| WO2023196892A1 (fr) | 2022-04-06 | 2023-10-12 | The Trustees Of The University Of Pennsylvania | Immunisation passive avec des anticorps neutralisants anti-aav pour empêcher la transduction hors cible de vecteurs aav administrés par voie intrathécale |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070172460A1 (en) * | 2003-03-19 | 2007-07-26 | Jurgen Kleinschmidt | Random peptide library displayed on aav vectors |
| DK3211085T3 (da) * | 2003-09-30 | 2021-06-21 | Univ Pennsylvania | Klader af adeno-associeret virus (aav), sekvenser, vektorer indeholdende disse og anvendelser deraf |
| DK2359867T3 (en) | 2005-04-07 | 2015-01-05 | Univ Pennsylvania | A method for increasing an AAV vector function |
| WO2016049230A1 (fr) * | 2014-09-24 | 2016-03-31 | City Of Hope | Variants de vecteur de virus adénoassocié pour une édition de haute efficacité du génome et procédés correspondants |
| EP3224362A4 (fr) * | 2014-11-26 | 2018-06-06 | The Regents of The University of California | Compositions thérapeutiques comprenant des facteurs de transcription et leurs procédés de préparation et d'utilisation |
| IL298604A (en) * | 2016-04-15 | 2023-01-01 | Univ Pennsylvania | Novel aav8 mutant capsids and preparations containing them |
| MX2019000962A (es) * | 2016-07-26 | 2019-08-01 | Biomarin Pharm Inc | Novedosas proteinas de la capside del virus adenoasociado. |
| TN2019000047A1 (en) * | 2016-08-15 | 2020-07-15 | Genzyme Corp | Methods for detecting aav |
| HRP20240257T1 (hr) * | 2017-02-28 | 2024-05-24 | The Trustees Of The University Of Pennsylvania | Adeno-povezani virusni (aav) clade f vektor i njegova uporaba |
| JOP20190200A1 (ar) * | 2017-02-28 | 2019-08-27 | Univ Pennsylvania | تركيبات نافعة في معالجة ضمور العضل النخاعي |
-
2019
- 2019-02-27 BR BR112020017278-2A patent/BR112020017278A2/pt unknown
- 2019-02-27 CA CA3091795A patent/CA3091795A1/fr active Pending
- 2019-02-27 MA MA052087A patent/MA52087A/fr unknown
- 2019-02-27 KR KR1020207027462A patent/KR20210006327A/ko active Search and Examination
- 2019-02-27 AU AU2019228504A patent/AU2019228504A1/en active Pending
- 2019-02-27 MX MX2020008932A patent/MX2020008932A/es unknown
- 2019-02-27 US US16/975,545 patent/US20210123073A1/en active Pending
- 2019-02-27 CN CN201980029022.1A patent/CN112236443A/zh active Pending
- 2019-02-27 WO PCT/US2019/019861 patent/WO2019169004A1/fr unknown
- 2019-02-27 JP JP2020545159A patent/JP7498665B2/ja active Active
- 2019-02-27 SG SG11202007942YA patent/SG11202007942YA/en unknown
- 2019-02-27 EP EP19760152.9A patent/EP3768695A4/fr active Pending
-
2020
- 2020-08-23 IL IL276860A patent/IL276860A/en unknown
- 2020-08-26 CL CL2020002201A patent/CL2020002201A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20210123073A1 (en) | 2021-04-29 |
| SG11202007942YA (en) | 2020-09-29 |
| KR20210006327A (ko) | 2021-01-18 |
| CL2020002201A1 (es) | 2020-12-18 |
| EP3768695A1 (fr) | 2021-01-27 |
| JP7498665B2 (ja) | 2024-06-12 |
| WO2019169004A9 (fr) | 2019-10-31 |
| WO2019169004A1 (fr) | 2019-09-06 |
| MX2020008932A (es) | 2020-10-01 |
| CA3091795A1 (fr) | 2019-09-06 |
| EP3768695A4 (fr) | 2022-04-06 |
| WO2019169004A8 (fr) | 2019-12-05 |
| BR112020017278A2 (pt) | 2020-12-22 |
| JP2021515548A (ja) | 2021-06-24 |
| IL276860A (en) | 2020-10-29 |
| AU2019228504A1 (en) | 2020-09-10 |
| CN112236443A (zh) | 2021-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA52087A (fr) | Nouveaux vecteurs de virus adéno-associés (aav), vecteurs aav ayant une déamidation de capside réduite et leurs utilisations | |
| IL276859A (en) | Novel adeno-associated virus (AAV) vectors, AAV vectors with reduced capsid deamidation and uses thereof | |
| DK3596222T3 (da) | Adenoassocieret virusvektorfremføring af muskelspecifik mikro-dystrophin til behandling af muskeldystrofi | |
| DK3684423T3 (da) | Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf | |
| TR201901582T4 (tr) | Kapsid | |
| PH12020500466A1 (en) | Lipid nanoparticle formulations of non-viral, capsid-free dna vectors | |
| DK3445773T3 (da) | Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf | |
| MA44681A (fr) | Administration de b-sarcoglycane et de microarn-29 à l'aide d'un vecteur de virus adéno-associé, et traitement de la dystrophie musculaire | |
| MA42934A (fr) | Vecteurs de facteur viii à virus adéno-associé, particules virales associées et formulations thérapeutiques comprenant ceux-ci | |
| EA202091074A1 (ru) | Аденовирус и его применения | |
| ZA201806746B (en) | Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dystrophy | |
| CO2018007203A2 (es) | Focalización de péptidos para dirigir virus adenoasociados (aavs) | |
| EA201791562A1 (ru) | Антигены цитомегаловируса и их применения | |
| DK3472183T3 (da) | Variant adeno-associerede virus og fremgangsmåder til anvendelse | |
| EA201591992A1 (ru) | Эффективная доставка больших генов посредством двойных aav векторов | |
| EA201890355A1 (ru) | Новые способы индукции иммунного ответа | |
| EA201792500A1 (ru) | Aav-опосредованная экспрессия антител против гриппа и способы их использования | |
| DK3584252T3 (da) | Human immundefektvirus-antigener, -vektorer, -sammensætninger og fremgangsmåder til anvendelse deraf | |
| PE20150163A1 (es) | Composicion y metodos para una transferencia de genes altamente eficiente usando variantes capside aav | |
| MA49298A (fr) | Virus de la maladie de newcastle et leurs utilisations | |
| EA201792418A1 (ru) | Применение cd24 для снижения уровней холестерина липопротеинов низкой плотности | |
| CY1125031T1 (el) | Μεθοδος για γενετικη θεραπεια χρησιμοποιωντας τον ιο aav-xbp1s/gfp και χρηση αυτης στην προληψη και τη θεραπεια της αμυοτροφικης πλευρικης σκληρυνσης | |
| EA202091104A1 (ru) | Аденовирус и пути его применения | |
| SG11201704919SA (en) | Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav) | |
| IL299380A (en) | An improved adenovirus as a vector for gene therapy |